Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Reduction in the incidence of dementia obtained with antihypertensive treatment

Nov. 5, 1998

Highly potent H3 receptor antagonist with potential therapeutic use

Nov. 5, 1998

Chinese researchers report that synthetic calcium antagonist improves memory dysfunction

Nov. 5, 1998

Angiotech study of micellar paclitaxel in MS well under way

Nov. 5, 1998

Bayer announces setback in AD drug development

Nov. 5, 1998

New sigma-receptor ligands presented by Sumitomo

Nov. 5, 1998

GlyT-1 technology forms the basis of Allelix and Janssen neuropsychiatric collaboration

Nov. 4, 1998

Meiji Seika discloses new neuroprotective substance isolated from fungus

Nov. 4, 1998

Novel isoquinoline anticonvulsants in development at SB

Nov. 4, 1998

Entropin concentrates its efforts on bringing Esterom to market

Nov. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...